Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

The announcement is Amazon’s most recent move into the pharmacy space Amazon Amazon continued its move into the pharmacy ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

The tracker allows patients to self-identify, provide their location, and say which brand of GLP-1 drug they are not able to find. The data will be aggregated and regularly published by Hims in ...